Guardant Health CFO exercises 7,278 RSUs
Guardant Health, Inc.’s Chief Financial Officer Michael Brian Bell reported routine equity compensation activity involving restricted stock units that vested into common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Guardant Health, Inc.’s Chief Financial Officer Michael Brian Bell reported routine equity compensation activity involving restricted stock units that vested into common stock. On July 1, 2026, RSU conversions delivered 7,278 shares of common stock, while 3,914 shares were withheld at $170.77 per share to cover tax obligations, rather than sold in the open market.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,084 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 3,324 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,870 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,084 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,324 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,870 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 3,914 | $170.77 | $668K |
Footnotes (5)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F3. Not applicable for Restricted Stock Units.
- F4. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F5. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
Key Figures
Key Terms
Restricted Stock Units financial
tax withholding obligations financial
derivative security financial
restricted stock unit award financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Guardant Health (GH) CFO Michael Brian Bell report in this Form 4?
Were any of the Guardant Health CFO’s transactions open-market buys or sells?
What are the vesting terms of the December 13, 2023 RSU grant at Guardant Health?
What vesting schedule applies to the November 8, 2024 RSU award at Guardant Health?
How does the March 12, 2025 Guardant Health RSU grant vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.